IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction

NCT01007461 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision. Non-safety related

Conditions

ST-Segment Elevation Myocardial Infraction

Interventions

DRUG: Sodium Sulfide (Na2S) for Injection
DRUG: Placebo

Sponsor

Mallinckrodt